Testing a new drug with radiation for aggressive brain tumors
Part of Cancer clinical trials.
This trial tests a new oral drug called XRD-0394 given together with radiation therapy for people with high-grade glioma, a type of aggressive brain tumor. The goal is to see if adding this drug makes radiation more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a high-grade glioma (a fast-growing brain tumor), confirmed by a biopsy or imaging.
- Your liver and kidney function are within safe limits for the study.
- You are able to care for yourself (ECOG performance status 0-2).
- If you are of childbearing potential, you agree to use highly effective birth control during the study.
- You have not had radiation to the same brain area before (for newly diagnosed patients) or your tumor has come back and it's been at least 3 months since your last brain radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy for glioblastoma (a type of brain cancer) using a machine that combines MRI imaging with radiation. The goal is to safely intensify the treatment and improve outcomes.
This study is testing a new way to target radiation for people with high-grade gliomas (aggressive brain tumors). The goal is to see if a more precise treatment plan can improve outcomes while keeping side effects low.
This trial tests a new drug, BDTX-1535, for people with a type of brain tumor called high-grade glioma that has a specific change in the EGFR gene. The study looks at how the drug works in the body and how safe it is for both newly diagnosed and recurrent tumors.
This trial tests a new two-part treatment (DB107-RRV and DB107-FC) combined with radiation, with or without the chemotherapy drug temozolomide, for people with newly diagnosed high-grade glioma. It aims to see if this approach is safe and effective.
This study tests a combination of three treatments for newly diagnosed high-grade glioma: a drug called ADI-PEG 20, chemotherapy (temozolomide), and radiation therapy. The goal is to see if this combination is safe and effective for children and young adults with this type of brain or spinal cord tumor.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
Hear when a new High Grade Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.